Invention Grant
- Patent Title: Heterocycle amide T-type calcium channel antagonists
- Patent Title (中): 杂环酰胺T型钙通道拮抗剂
-
Application No.: US13500097Application Date: 2010-10-25
-
Publication No.: US08987310B2Publication Date: 2015-03-24
- Inventor: James Barrow , Kelly-Ann Schlegel , Yoheng Shu , Zhi-Qiang Yang
- Applicant: James Barrow , Kelly-Ann Schlegel , Yoheng Shu , Zhi-Qiang Yang
- Applicant Address: US NJ Rahway
- Assignee: Merck Sharp & Dohme Corp.
- Current Assignee: Merck Sharp & Dohme Corp.
- Current Assignee Address: US NJ Rahway
- Agent J. Eric Thies; John C. Todaro
- International Application: PCT/US2010/053908 WO 20101025
- International Announcement: WO2011/053542 WO 20110505
- Main IPC: C07D401/12
- IPC: C07D401/12 ; A61K31/4439 ; C07D401/06 ; C07D233/64 ; C07D249/04 ; C07D257/04 ; C07D271/10 ; C07D277/28 ; C07D413/04 ; C07D413/06 ; C07D417/14 ; C07D263/32
Abstract:
The present invention is directed to heterocycle amide compounds which are antagonists of T-type calcium channels, and which are useful in the treatment or prevention of disorders and diseases in which T-type calcium channels are involved. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which T-type calcium channels are involved.
Public/Granted literature
- US20120202852A1 HETEROCYCLE AMIDE T-TYPE CALCIUM CHANNEL ANTAGONISTS Public/Granted day:2012-08-09
Information query
